# | Title | Journal | Year | Citations |
---|
1 | Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus | Gut | 2013 | 4,813 |
2 | Global patterns and trends in colorectal cancer incidence and mortality | Gut | 2017 | 3,497 |
3 | The risk of colorectal cancer in ulcerative colitis: a meta-analysis | Gut | 2001 | 2,433 |
4 | The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications | Gut | 2006 | 2,362 |
5 | Short chain fatty acids in human large intestine, portal, hepatic and venous blood. | Gut | 1987 | 2,348 |
6 | Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report | Gut | 2017 | 2,245 |
7 | Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability | Gut | 2009 | 2,061 |
8 | Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report | Gut | 2012 | 2,023 |
9 | Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification | Gut | 1999 | 1,959 |
10 | Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach | Gut | 2006 | 1,931 |
11 | The Vienna classification of gastrointestinal epithelial neoplasia | Gut | 2000 | 1,838 |
12 | The gut microbiota and host health: a new clinical frontier | Gut | 2016 | 1,719 |
13 | Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report | Gut | 2007 | 1,706 |
14 | Epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut | 2005 | 1,522 |
15 | Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut | 2014 | 1,444 |
16 | Increased expression of interleukin 17 in inflammatory bowel disease | Gut | 2003 | 1,436 |
17 | Endoscopic mucosal resection for treatment of early gastric cancer | Gut | 2001 | 1,379 |
18 | Akkermansia muciniphilaand improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology | Gut | 2016 | 1,379 |
19 | A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitis | Gut | 2014 | 1,353 |
20 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut | 2019 | 1,353 |
21 | The Oslo definitions for coeliac disease and related terms | Gut | 2013 | 1,300 |
22 | Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial | Gut | 2012 | 1,295 |
23 | Functional bowel disorders and functional abdominal pain | Gut | 1999 | 1,294 |
24 | An increase in theAkkermansiaspp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice | Gut | 2014 | 1,288 |
25 | Kyoto global consensus report onHelicobacter pylorigastritis | Gut | 2015 | 1,256 |
26 | Hepatocellular carcinoma: clinical frontiers and perspectives | Gut | 2014 | 1,180 |
27 | Prospective comparison of faecal incontinence grading systems | Gut | 1999 | 1,157 |
28 | Risk assessment after acute upper gastrointestinal haemorrhage. | Gut | 1996 | 1,145 |
29 | Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. | Gut | 1980 | 1,134 |
30 | Guidelines for the management of inflammatory bowel disease in adults | Gut | 2011 | 1,127 |
31 | British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus | Gut | 2014 | 1,116 |
32 | Global incidence of oesophageal cancer by histological subtype in 2012 | Gut | 2015 | 1,110 |
33 | High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome | Gut | 2016 | 1,092 |
34 | Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease | Gut | 2004 | 1,073 |
35 | Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study | Gut | 2006 | 1,063 |
36 | Butyrate inhibits inflammatory responses through NFkappa B inhibition: implications for Crohn's disease | Gut | 2000 | 1,060 |
37 | A simple clinical colitis activity index | Gut | 1998 | 1,054 |
38 | Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms | Gut | 2020 | 1,044 |
39 | Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine | Gut | 2004 | 1,012 |
40 | Measurement of gastrointestinal pH profiles in normal ambulant human subjects. | Gut | 1988 | 1,008 |
41 | Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease | Gut | 2007 | 1,005 |
42 | Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002) | Gut | 2010 | 1,000 |
43 | Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening | Gut | 2009 | 999 |
44 | Modern diagnosis of GERD: the Lyon Consensus | Gut | 2018 | 991 |
45 | Exercise and associated dietary extremes impact on gut microbial diversity | Gut | 2014 | 987 |
46 | Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome | Gut | 2000 | 977 |
47 | Human gut microbiome: hopes, threats and promises | Gut | 2018 | 957 |
48 | Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults | Gut | 2015 | 950 |
49 | Fungal microbiota dysbiosis in IBD | Gut | 2017 | 939 |
50 | Short chain fatty acids in the human colon. | Gut | 1981 | 929 |